These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 24783944)

  • 21. Altered gene expression in asymptomatic SHIV-infected rhesus macaques (Macacca mulatta).
    Carroll EE; Hammamieh R; Chakraborty N; Phillips AT; Miller SA; Jett M
    Virol J; 2006 Sep; 3():74. PubMed ID: 16956415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
    Igarashi T; Imamichi H; Brown CR; Hirsch VM; Martin MA
    J Leukoc Biol; 2003 Nov; 74(5):772-80. PubMed ID: 14595005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repressive effect of primary virus replication on superinfection correlated with gut-derived central memory CD4(+) T cells in SHIV-infected Chinese rhesus macaques.
    Xue J; Cong Z; Xiong J; Wang W; Jiang H; Chen T; Wu F; Liu K; Su A; Ju B; Chen Z; Couto MA; Wei Q; Qin C
    PLoS One; 2013; 8(9):e72295. PubMed ID: 24023734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses.
    Tsibris AM; Pal U; Schure AL; Veazey RS; Kunstman KJ; Henrich TJ; Klasse PJ; Wolinsky SM; Kuritzkes DR; Moore JP
    PLoS One; 2011; 6(12):e28047. PubMed ID: 22164225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Robust suppression of env-SHIV viremia in Macaca nemestrina by 3-drug ART is independent of timing of initiation during chronic infection.
    Peterson CW; Younan P; Polacino PS; Maurice NJ; Miller HW; Prlic M; Jerome KR; Woolfrey AE; Hu SL; Kiem HP
    J Med Primatol; 2013 Oct; 42(5):237-46. PubMed ID: 24025078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.
    Kirchhoff F
    Cell Host Microbe; 2010 Jul; 8(1):55-67. PubMed ID: 20638642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques.
    Wang W; Yao N; Cong Z; Jiang H; Qin C; Wei Q
    AIDS Res Ther; 2014 Mar; 11(1):12. PubMed ID: 24594071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aikeqing decreases viral loads in SHIV89.6-infected Chinese rhesus macaques.
    Zhang GH; Han JB; Zhu L; Luo RH; Zhang XH; Chen X; Hu YJ; Fu LC; Zheng YT
    Chin Med; 2016; 11():31. PubMed ID: 27375770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of chance in primate lentiviral infectivity: from protomer to host organism.
    Regoes RR; Magnus C
    Prog Mol Biol Transl Sci; 2015; 129():327-51. PubMed ID: 25595809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primate immunodeficiency virus classification and nomenclature: Review.
    Foley BT; Leitner T; Paraskevis D; Peeters M
    Infect Genet Evol; 2016 Dec; 46():150-158. PubMed ID: 27789390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques.
    Bauer A; Lindemuth E; Marino FE; Krause R; Joy J; Docken SS; Mallick S; McCormick K; Holt C; Georgiev I; Felber B; Keele BF; Veazey R; Davenport MP; Li H; Shaw GM; Bar KJ
    PLoS Pathog; 2023 Jul; 19(7):e1011059. PubMed ID: 37399208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between NK Cells in Different Immune Organs and Cellular SIV DNA and RNA in Regional HLADR
    Li X; Zhu L; Yin Y; Fan X; Lv L; Zhang Y; Pan Y; Yan Y; Liang H; Xue J; Shen T
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Antibodies with Broad Neutralization Specificities against HIV-1 after Long Term SHIV Infection in Macaques.
    Gao N; Gai Y; Meng L; Wang C; Zhang X; Wang W; Qin C; Yu X; Gao F
    Viruses; 2020 Jan; 12(2):. PubMed ID: 32023860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of viral burden and disease progression in Chinese-origin rhesus macaques infected with common experimentally applied chimeric virus: SHIV-1157ipd3N4, SHIV-162P3, or SHIV-KB9.
    Wang W; Cong Z; Jiang H; Chen T; Jin G; Xiong J; Qin C; Wei Q
    J Med Primatol; 2014 Aug; 43(4):247-57. PubMed ID: 24783944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.